Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Grand Hoyo
Wuhan, Hubei, China
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
01
Overview
Wuhan Grand Hoyo is a specialized pharmaceutical company focused on the production of amino acids and their derivatives via fermentation and extraction. As a key subsidiary of Grand Pharmaceutical (China), it is a leading global supplier of N-acetyl-L-cysteine and carbocisteine APIs used in mucolytic therapies.
- Therapeutic areas
- GastroenterologyPulmonologyInfectious DiseasesMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Contract Manufacturing Organization
02
Partnerships
NestléDanoneAbbott Laboratories
Beyond the preview
Go deeper on Wuhan Grand Hoyo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Wuhan Grand Hoyo.